Home>Topics>Drug Companies

Drug Companies

  1. All
  2. Commentary
  3. Stock Reports
  4. Video Reports
  5. Fund Reports
  6. ETF Reports
  7. Headlines
  1. Heart drug launch could be "most exciting ever", says Novartis

    Headlines

    Sun, 31 Aug 2014

    BARCELONA, Aug 31 (Reuters) - The expected launch of Novartis's new heart failure drug next year promises to be the company's most exciting ever and profit margins on the medicine will be good, its head of pharmaceuticals said on Sunday.

  2. Belviq Sales Crack Critical Level

    Headlines

    Fri, 29 Aug 2014

    By Spencer Osborne : Sales of the anti-obesity Drug Belviq from Arena Pharmaceuticals (NASDAQ: ARNA ) passed a critical level today with an improvement of 3.4% over the numbers last week. For the first time

  3. Morningstar's Most Popular

    Headlines

    Fri, 29 Aug 2014

    Most Requested Stock Quotes Apple IBM Schlumberger Berkshire Hathaway AT&T Most Requested Stock Analyses Lexicon Pharmaceuticals Procter & Gamble HCP Schlumberger Enterprise Product Partners Most Requested Fund Quotes Vanguard Dividend Growth

  4. Fitch Maintains CFR's IDRs on Rating Watch Positive

    Headlines

    Fri, 29 Aug 2014

    following statement was released by the rating agency) CHICAGO, August 29 (Fitch) Fitch Ratings maintains CFR Pharmaceuticals S.A. and its subsidiary CFR International SpA on Rating Watch Positive in anticipation of their acquisition

  5. Tiny Tribute Getting Bigger And Warranting More Attention

    Headlines

    Fri, 29 Aug 2014

    By Brian Marckx, CFA : Tribute Pharmaceuticals (OTCQX: TBUFF ) is a small Canadian specialty pharmaceutical company which in-licenses products for sale in the U.S. and

  6. DelMar Pharma reports results for six-month period ended June 30

    Headlines

    Fri, 29 Aug 2014

    DelMar Pharmaceuticals ( OTCQB:DMPI ) six-month results : Revenues: $0; Operating Expenses: $2.7M (-27.5%); Net Loss: ($2.8M

  7. Pharma companies reportedly eyeing Belgian drug firm

    Headlines

    Fri, 29 Aug 2014

    the situation say that the Belgian OTC drug maker Omega Pharma NV has attracted interest from a number of pharmaceutical companies including Perrigo (NYSE: PRGO ), Boehringer Ingelheim, Bayer ( OTCPK:BAYZF ) ( OTCPK:BAYRY ) and Sanofi

  8. BioCryst receives additional funding for Ebola treatment testing

    Headlines

    Fri, 29 Aug 2014

    The National Institute of Allergy and Infectious Diseases (NIAID) awards BioCryst Pharmaceuticals (NASDAQ: BCRX ) a contract modification for an additional $2.4M to fund a dose ranging efficacy study of an intramuscular

  9. UPDATE 1-BioCryst expects to begin Ebola study in weeks

    Headlines

    Fri, 29 Aug 2014

    Aug 29 (Reuters) - BioCryst Pharmaceuticals Inc said it expects to initiate a study within weeks to test its antiviral in primates for use against Ebola infections

  10. Takeda loses bid to overturn $9B damage award

    Headlines

    Fri, 29 Aug 2014

    U.S. District Court of the Western District of Louisiana Judge Rebecca Doherty rules that the label of Takeda Pharmaceuticals ' diabetes drug Actos did not adequately warn patients about the increased cancer risk. The $9B punitive damages awarded

« Prev12345Next »
Content Partners